Nutrient quality
The practical extract amount and focused composition fit the intended use well. Missing active-acid standards and plain capsule delivery limit form quality.
| $ 23.99 | ||
| $ 24.44 | ||
Vitacost | $ 25.53 | |
Amazon | $ 23.99 |
Each capsule provides 400 mg of Boswellia resin extract. The substantial serving and single-botanical design give the product a clear joint-comfort purpose at good practical value.
Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.
No boswellic-acid percentage, AKBA level, or absorption technology is disclosed, making potency difficult to compare. The 90-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.
The practical extract amount and focused composition fit the intended use well. Missing active-acid standards and plain capsule delivery limit form quality.
The extract amount is clear and no proprietary blend is used. Active strength, complete directions, and non-active ingredients remain undisclosed.
The supplied average rating is strong and the rating volume is substantial. No specific experience details were provided to judge repeated complaints or purpose alignment.
A useful extract amount at a favorable serving cost provides strong practical value. More complete potency specification would strengthen its position against standardized options.
Boswellia directly targets the 5-LOX pathway and is well aligned with inflammatory and joint-comfort support. The disclosed extract amount falls within a meaningful range.
Missing boswellic-acid standardization, AKBA content, and absorption support prevent a strong potency judgment. The single-botanical design is focused but does not cover oxidative or immune pathways.
Boswellia resin extract directly targets inflammatory pathways involved in joint discomfort and is well aligned with mobility support. Evidence is strongest for standardized extracts, but no boswellic-acid content is stated here.
The 400 mg amount is substantial for an extract, while missing standardization makes potency difficult to compare with studied products. The focused formula offers no cartilage building blocks or lubrication ingredients.
| Ingredient | Amount per serving |
|---|---|
Boswellia resin extract | 400 mg |
The 400 mg extract amount fits the standard clinical range, but no boswellic acid or AKBA standardization is stated. The dry capsule provides no special absorption support. A low serving cost offers good practical value despite incomplete potency detail.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.